'''Crystal structure of clavulanic acid bound to E166A variant of SHV-1 beta-lactamase'''
===Crystal structure of clavulanic acid bound to E166A variant of SHV-1 beta-lactamase===
==Overview==
<!--
Antibiotic resistance mediated by constantly evolving beta-lactamases is a serious threat to human health. The mechanism of inhibition of these enzymes by therapeutic beta-lactamase inhibitors is probed using a novel approach involving Raman microscopy and x-ray crystallography. We have presented here the high resolution crystal structures of the beta-lactamase inhibitors sulbactam and clavulanic acid bound to the deacylation-deficient E166A variant of SHV-1 beta-lactamase. Our previous Raman measurements have identified the trans-enamine species for both inhibitors and were used to guide the soaking time and concentration to achieve full occupancy of the active sites. The two inhibitor-bound x-ray structures revealed a linear trans-enamine intermediate covalently attached to the active site Ser-70 residue. This intermediate was thought to play a key role in the transient inhibition of class A beta-lactamases. Both the Raman and x-ray data indicated that the clavulanic acid intermediate is decarboxylated. When compared with our previously determined tazobactam-bound inhibitor structure, our new inhibitor-bound structures revealed an increased disorder in the tail region of the inhibitors as well as in the enamine skeleton. The x-ray crystallographic observations correlated with the broadening of the O-C=C-N (enamine) symmetric stretch Raman band near 1595 cm(-1). Band broadening in the sulbactam and clavulanic acid inter-mediates reflected a heterogeneous conformational population that results from variations of torsional angles in the O-(C=O)-C=C=NH-C skeleton. These observations led us to conclude that the conformational stability of the trans-enamine form is critical for their transient inhibitory efficacy.
The line below this paragraph, {{ABSTRACT_PUBMED_16055923}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16055923 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16055923}}
==About this Structure==
==About this Structure==
Line 36:
Line 40:
[[Category: Inhibitor design]]
[[Category: Inhibitor design]]
[[Category: Penicillinase]]
[[Category: Penicillinase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 18:34:58 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:28:19 2008''
Revision as of 11:28, 28 July 2008
This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.
Crystal structure of clavulanic acid bound to E166A variant of SHV-1 beta-lactamaseCrystal structure of clavulanic acid bound to E166A variant of SHV-1 beta-lactamase
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase., Padayatti PS, Helfand MS, Totir MA, Carey MP, Carey PR, Bonomo RA, van den Akker F, J Biol Chem. 2005 Oct 14;280(41):34900-7. Epub 2005 Jul 29. PMID:16055923
